{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-004933","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2023-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.711180+00:00","generated_at":"2026-06-13T08:07:26.040553+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Sonoma Pharmaceuticals appoints Controller and sets new interim CFO consulting terms","bullets":["John Dal Poggetto appointed Controller effective July 17, 2023; annual salary $100,000, bonus up to 20%, option grant for 5,000 shares vesting over three years.","New consulting agreement with Jerome Dvonch Consulting, LLC at $20,000/month, effective August 15, 2023, with Dvonch continuing as interim CFO.","Dvonch's vested equity awards extended by one extra month per month of continued service, capped by current plan provisions.","Dal Poggetto will work part-time, reporting to interim CFO Dvonch; role is at-will with standard benefits and 3 weeks vacation.","No changes to other executive officers or board composition disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-004933","json":"https://secwatch.observer/filing/0001683168-23-004933.json","markdown":"https://secwatch.observer/filing/0001683168-23-004933.md","text":"https://secwatch.observer/filing/0001683168-23-004933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823004933/0001683168-23-004933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823004933/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:07:26.040553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eb4e419ecb","claim":"John Dal Poggetto was appointed as Controller at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective July 17, 2023, our Board of Directors appointed John Dal Poggetto as our Controller.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823004933/0001683168-23-004933-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Controller"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}